Ichiro Kikushige Named CEO of Teva Seiyaku, Japan

Teva Pharmaceutical Industries TEVA today announced the appointment of Ichiro Kikushige as Chief Executive Officer (CEO) of Teva Seiyaku, Japan, effective on May 15, 2013. Mr. Kikushige most recently was Senior Director of Sales for Eli Lilly Japan K.K. Mr. Kikushige will replace Makoto Shimada, currently President and CEO of Teva Seiyaku, who is retiring after having served the pharmaceutical industry in Japan for nearly 40 years. Mr. Shimada will remain at Teva Seiyaku until June 30, 2013 to facilitate a smooth and orderly transition. “As an effective leader with more than 30 years of experience in the pharmaceutical industry, Mr. Kikushige is well-qualified to assume this important role within Teva in Japan,” said Prof. Itzhak Krinsky, See full press release